![](/images/graphics-bg.png)
Synthesis of Novel 1,2,4-Triazolyl Coumarin Derivatives as Potential Anticancer Agents
Joint Authors
Al-Wahaibi, Lamya H.
Abu-Melha, Hanaa M.
Ibrahim, Diaa A.
Source
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-8, 8 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-10-14
Country of Publication
Egypt
No. of Pages
8
Main Subjects
Abstract EN
A series of novel coumarin derivatives carrying 1,2,4-triazole or 1,2,4-triazolo[3,4-b][1,3,4]thiadiazole moieties were prepared and evaluated in vitro as anticancer in the human colon cancer (HCT116) cell line.
The derivatives 4c and 8c exhibited marked anticancer activity with IC50 values 4.363 and 2.656 µM, respectively.
The molecular docking studies suggested possible interaction with tyrosine kinases (CDK2).
American Psychological Association (APA)
Al-Wahaibi, Lamya H.& Abu-Melha, Hanaa M.& Ibrahim, Diaa A.. 2018. Synthesis of Novel 1,2,4-Triazolyl Coumarin Derivatives as Potential Anticancer Agents. Journal of Chemistry،Vol. 2018, no. 2018, pp.1-8.
https://search.emarefa.net/detail/BIM-1182417
Modern Language Association (MLA)
Al-Wahaibi, Lamya H.…[et al.]. Synthesis of Novel 1,2,4-Triazolyl Coumarin Derivatives as Potential Anticancer Agents. Journal of Chemistry No. 2018 (2018), pp.1-8.
https://search.emarefa.net/detail/BIM-1182417
American Medical Association (AMA)
Al-Wahaibi, Lamya H.& Abu-Melha, Hanaa M.& Ibrahim, Diaa A.. Synthesis of Novel 1,2,4-Triazolyl Coumarin Derivatives as Potential Anticancer Agents. Journal of Chemistry. 2018. Vol. 2018, no. 2018, pp.1-8.
https://search.emarefa.net/detail/BIM-1182417
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1182417